JNJ vs RMD
By Alex · Tickerpine
Johnson & Johnson vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | RMD |
|---|---|---|
| Price | $254.66 | $200.29 |
| Market cap | $613.02B | $29.05B |
| P/E ratio | 29.5 | 19.3 |
| ROE | 26.42% | 25.25% |
| Profit margin | 21.83% | 27.44% |
| Revenue growth | 9.90% | 10.80% |
| Dividend yield | 2.10% | 1.20% |
| Beta | 0.26 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs RMD in plain English
- JNJ is the bigger company — about 21.1× the market cap of RMD.
- RMD is cheaper on earnings (P/E 19.3 vs 29.5).
- JNJ earns a higher return on equity (26% vs 25%).
- RMD is growing revenue faster (11% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 1.20%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.